Jeffrey Chan

2.3k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Jeffrey Chan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Jeffrey Chan has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Otorhinolaryngology. Recurrent topics in Jeffrey Chan's work include Head and Neck Cancer Studies (5 papers), Brain Metastases and Treatment (4 papers) and Bone health and treatments (3 papers). Jeffrey Chan is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Brain Metastases and Treatment (4 papers) and Bone health and treatments (3 papers). Jeffrey Chan collaborates with scholars based in China, Hong Kong and Australia. Jeffrey Chan's co-authors include S. E. Harris, Gregory R. Mundy, Ming Zhao, R.J. Burriss Garrett, Brendan F. Boyce, G. Gutierrez, G. Rossini, Belinda A. Di Bartolo, Martin R. Bennett and Mary M. Kavurma and has published in prestigious journals such as Science, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jeffrey Chan

18 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stimulation of Bone Formation in Vitro and in Rodents by Statins

1999 1.4k citations Gregory R. Mundy, R.J. Burriss Garrett et al. Science profile →

Peers

Countries citing papers authored by Jeffrey Chan

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Chan more than expected).

Fields of papers citing papers by Jeffrey Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Chan. The network helps show where Jeffrey Chan may publish in the future.

Co-authorship network of co-authors of Jeffrey Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Chan. A scholar is included among the top collaborators of Jeffrey Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Chan. Jeffrey Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma 2023 ·JAMA Network Open ·James Chung Hang Chow, Wah Cheuk, William C. Cho, (unknown), (unknown), Anthony H.P. Tam, (unknown), Jeffrey Chan, (unknown), Roger K.C. Ngan, (unknown), Ka Man Cheung	1
2	The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium 2021 ·Cancer Science ·Tom Wei‐Wu Chen, Angela Pang, Mark E. Puhaindran, (unknown), Herbert H. Loong, Virote Sriuranpong, (unknown), (unknown), Takeshi Hirose, Makoto Endo, Akira Kawai, Mohamad Farid, Sze Huey Tan, Wei Lin Goh, Richard Quek, Jeffrey Chan, (unknown), Roger K.C. Ngan	10
3	Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy 2021 ·Radiotherapy and Oncology ·James Chung Hang Chow, Anna Lee, (unknown), Ka Man Cheung, Jeffrey Chan, Anthony H.P. Tam, (unknown), (unknown), (unknown), (unknown), (unknown), Anussara Prayongrat, Chawalit Lertbutsayanukul, Danita Kannarunimit, (unknown), Sarin Kitpanit	1
4	The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer 2021 ·JAMA Network Open ·(unknown), (unknown), (unknown), Ka Man Cheung, Jeffrey Chan	38
5	Clinical application of circulating tumor DNA in breast cancer 2021 ·Journal of Cancer Research and Clinical Oncology ·Jeffrey Chan, James Chung Hang Chow, (unknown), (unknown), William C. Cho	11
6	The association of HER2 low expression with the efficacy of CDK4/6 inhibitor in hormone receptor positive HER2 negative metastatic breast cancer. 2021 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Ka Man Cheung, Jeffrey Chan	1
7	Application of hypoglossal nerve constraint in definitive radiotherapy for nasopharyngeal carcinoma: A dosimetric feasibility study 2020 ·Medical dosimetry ·James Chung Hang Chow, (unknown), Kwok‐Hung Au, Ka Man Cheung, Roger K.C. Ngan, (unknown), (unknown), Jeffrey Chan, (unknown), (unknown)	3
8	ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma 2019 ·Cancer Research ·Rohit Sachdeva, Megan Wu, (unknown), (unknown), (unknown), (unknown), Keren Isaev, A. Sorana Morrissy, (unknown), Jiefei Tong, Jeffrey Chan, (unknown), (unknown), David G. Muñoz, Peter B. Dirks, Michael F. Moran, Michael D. Taylor, Jüri Reimand, Sunit Das	49
9	Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose–toxicity relationship 2019 ·Radiotherapy and Oncology ·James Chung Hang Chow, Ka Man Cheung, Kwok‐Hung Au, Benny Zee, J. Jack Lee, Roger K.C. Ngan, Anne W.M. Lee, Harry Yiu, (unknown), (unknown), Jeffrey Chan, (unknown), (unknown)	21
10	Radiation-Induced Hypoglossal Nerve Palsy after Definitive Radiotherapy for Nasopharyngeal Carcinoma: Clinical Predictors and Dose-Toxicity Relationship 2019 ·International Journal of Radiation OncologyBiologyPhysics ·James Chung Hang Chow, Ka Man Cheung, Kwok Hung Au, Benny Zee, (unknown), Roger K.C. Ngan, (unknown), Harry Yiu, (unknown), (unknown), Jeffrey Chan, (unknown), (unknown)	2
11	Albumin-Bilirubin Versus Child-Pugh Score as a Predictor of Survival After Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma 2017 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Chi‐Leung Chiang, (unknown), Jeffrey Chan, Cynthia Yeung, (unknown), Frank Chi Sing Wong, (unknown)	1
12	502O_PR Optimal first line systemic therapy in patients (pts) with metastatic angiosarcoma: A report from the Asian Sarcoma Consortium 2016 ·Annals of Oncology ·(unknown), Angela Pang, Mark E. Puhaindran, (unknown), Herbert H. Loong, Virote Sriuranpong, Cheng‐Chang Chang, (unknown), (unknown), Takeshi Hirose, Makoto Endo, Akira Kawai, Mohamad Farid, Sze Huey Tan, Wei Lin Goh, R. Quek, Jeffrey Chan, (unknown), Roger K.C. Ngan	2
13	Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity 2015 ·Innate Immunity ·Khalil Karimi, (unknown), Jeffrey Chan, Jeanette E. Boudreau, (unknown), Marianne V. Chew, Sarah Reid, Jonathan L. Bramson, Yonghong Wan, Ali A. Ashkar	13
14	TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice 2011 ·Diabetologia ·Belinda A. Di Bartolo, Jeffrey Chan, Martin R. Bennett, Siân P. Cartland, Shisan Bao, Bernard E. Tuch, Mary M. Kavurma	97
15	Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model 2011 ·PLoS ONE ·Tzong‐Tyng Hung, Jeffrey Chan, Pamela J. Russell, Carl Power	28
16	TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2–, Sp1 Phosphorylation–, and NFκB-Dependent Manner 2010 ·Circulation Research ·Jeffrey Chan, Leonel Prado-Lourenço, Levon M. Khachigian, Martin R. Bennett, Belinda A. Di Bartolo, Mary M. Kavurma	68
17	A novel model of bone‐metastatic prostate cancer in immunocompetent Mice 2009 ·The Prostate ·Carl Power, (unknown), Jeffrey Chan, (unknown), Yan Yu, William R. Walsh, Pamela J. Russell	40
18	Stimulation of Bone Formation in Vitro and in Rodents by Statins breakdown → 1999 ·Science ·Gregory R. Mundy, R.J. Burriss Garrett, S. E. Harris, Jeffrey Chan, (unknown), G. Rossini, Brendan F. Boyce, Ming Zhao, G. Gutierrez	1435

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact